Biosimilars studies require a cost-effective, global solution for both the efficient recruitment of healthy volunteers and for the collection of accurate data to help seamlessly transition studies from Phase I to Phase III. Quintiles has developed a comprehensive suite of services, with central oversight provided by experienced project managers, to help meet the demands of these trials and to fast track biosimilars development.